Products billed under this code include Dobutamine HCl, Dobutamine HCl In Dextrose.
Payment limit per 250 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Dobutamine HCl | Hikma Pharmaceuticals USA Inc. | 00143-9141-10 | 10 | $88.75 |
| Dobutamine HCl | Baxter Healthcare Corporation | 00338-1073-02 | 18 | $159.75 |
| Dobutamine HCl | Baxter Healthcare Corporation | 00338-1075-02 | 36 | $319.50 |
| Dobutamine HCl | Baxter Healthcare Corporation | 00338-1077-02 | 72 | $639.00 |
| Dobutamine HCl | Pfizer Inc | 00409-2344-01 | 1 | $8.875 |
| Dobutamine HCl | Pfizer Inc | 00409-2344-02 | 10 | $88.75 |
| Dobutamine HCl | Pfizer Inc | 00409-2344-88 | 10 | $88.75 |
| Dobutamine HCl | A-S Medication Solutions | 50090-4562-00 | 4 | $35.50 |
| Dobutamine HCl | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1330-01 | 2 | $17.75 |
| Dobutamine HCl | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1337-01 | 1 | $8.875 |
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Dobutamine HCl | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1337-03 | 10 | $88.75 |
| Dobutamine HCl | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1566-01 | 1 | $8.875 |
| Dobutamine HCl | Slate Run Pharmaceuticals | 70436-0203-80 | 1 | $8.875 |
| Dobutamine HCl | Slate Run Pharmaceuticals | 70436-0203-82 | 10 | $88.75 |
| Dobutamine HCl In Dextrose | Hospira, Inc. | 00409-0025-10 | 12 | $106.50 |
| Dobutamine HCl In Dextrose | Hospira, Inc. | 00409-0151-10 | 24 | $213.00 |
| Dobutamine HCl In Dextrose | Hospira, Inc. | 00409-1100-10 | 48 | $426.00 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $8.875 | +$1.184 | 250 MG | Inj dobutamine hcl/250 mg | v1, posted September 17, 2026 |
| 3Q26 | $7.691 | −$0.191 | 250 MG | Inj dobutamine hcl/250 mg | v1, posted September 15, 2026 |
| 2Q26 | $7.882 | −$0.142 | 250 MG | Inj dobutamine hcl/250 mg | v1, posted September 15, 2026 |
| 1Q26 | $8.024 | +$0.943 | 250 MG | Inj dobutamine hcl/250 mg | v1, posted September 15, 2026 |
| 4Q25 | $7.081 | −$0.896 | 250 MG | Inj dobutamine hcl/250 mg | v1, posted September 8, 2026 |
| 3Q25 | $7.977 | −$0.168 | 250 MG | Inj dobutamine hcl/250 mg | v1, posted March 10, 2026 |
| 2Q25 | $8.145 | +$0.755 | 250 MG | Inj dobutamine hcl/250 mg | v1, posted March 10, 2026 |
| 1Q25 | $7.39 | −$0.538 | 250 MG | Inj dobutamine hcl/250 mg | v1, posted December 19, 2025 |
| 4Q24 | $7.928 | +$0.347 | 250 MG | Inj dobutamine hcl/250 mg | v1, posted June 11, 2025 |
| 3Q24 | $7.581 | −$1.68 | 250 MG | Inj dobutamine hcl/250 mg | v1, posted June 11, 2025 |
| 2Q24 | $9.261 | −$0.587 | 250 MG | Inj dobutamine hcl/250 mg | v1, posted March 11, 2025 |
| 1Q24 | $9.848 | +$0.026 | 250 MG | Inj dobutamine hcl/250 mg | v1, posted December 19, 2024 |
| 4Q23 | $9.822 | +$0.997 | 250 MG | Inj dobutamine hcl/250 mg | v1, posted October 10, 2024 |
| 3Q23 | $8.825 | +$2.297 | 250 MG | Inj dobutamine hcl/250 mg | v1, posted June 5, 2024 |
| 2Q23 | $6.528 | −$0.44 | 250 MG | Inj dobutamine hcl/250 mg | v1, posted February 23, 2024 |
| 1Q23 | $6.968 | +$0.431 | 250 MG | Inj dobutamine hcl/250 mg | v1, posted December 6, 2023 |
| 4Q22 | $6.537 | +$0.187 | 250 MG | Inj dobutamine hcl/250 mg | v1, posted June 22, 2023 |
| 3Q22 | $6.35 | +$0.347 | 250 MG | Inj dobutamine hcl/250 mg | v1, posted June 9, 2023 |
| 2Q22 | $6.003 | −$0.795 | 250 MG | Inj dobutamine hcl/250 mg | v1, posted December 14, 2022 |
| 1Q22 | $6.798 | −$1.412 | 250 MG | Inj dobutamine hcl/250 mg | v1, posted June 8, 2022 |
| 4Q21 | $8.21 | +$1.246 | 250 MG | Inj dobutamine hcl/250 mg | v1, posted June 2, 2022 |
| 3Q21 | $6.964 | −$0.745 | 250 MG | Inj dobutamine hcl/250 mg | v1, posted June 2, 2022 |
| 2Q21 | $7.709 | +$0.518 | 250 MG | Inj dobutamine hcl/250 mg | v1, posted March 1, 2022 |
| 1Q21 | $7.191 | – | 250 MG | Inj dobutamine hcl/250 mg | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
